RETRACTED ARTICLE: Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted anti-tumor drug delivery system with sequential release functions
Open Access
- 25 September 2015
- journal article
- retracted article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 34 (1) , 1-9
Abstract
Background: Dual loading drug delivery system with tumor targeting efficacy and sequential release function provides a promising platform for anticancer drug delivery. Herein, we established a novel AuCOOH@FACS nanogel system for co-delivery miR-218 mimics (as bio-drug) and Temozolomide(as chemo-drug). Methods: DLS and TEM were employed to determine the characteristics of particles and nanogels. The cell viability was calculated for study synergistic effect of both drugs coadministration and in nanogel forms. The amounts of Au uptake were measured by ICP-MS in cell and tumors to quantify the targeting drug delivery efficacy. Tumor weight and mice weight were investigated to study the targeting antitumor efficacy of nanogel system. Results: The results revealed that using AuCOOH@FACS nanogel as delivery vehicles, drugs could be targeting delivery to tumor site, the intracellular uptake is enhanced to a greater extent, and significant antitumor efficacy is fold increase compared with free drug administration group, without noticeable system cytotoxicity. Conclusions: This system offers an efficient approach to cancer therapy and holds significant potential to improve the treatment of cancer in the future.Keywords
Funding Information
- National Natural Science Foundation of China (31440044)
- National Natural Science Foundation of China (81201179)
- National Natural Science Foundation of China (30901358)
- National Natural Science Foundation of China (81271687)
This publication has 24 references indexed in Scilit:
- Gold Nanoparticles: Synthesis and Applications in Drug DeliveryTropical Journal of Pharmaceutical Research, 2014
- Immunologic treatments for precancerous lesions and uterine cervical cancerJournal of Experimental & Clinical Cancer Research, 2014
- Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheresJournal of Experimental & Clinical Cancer Research, 2013
- Co‐delivery of 10‐Hydroxycamptothecin with Doxorubicin Conjugated Prodrugs for Enhanced Anticancer EfficacyMacromolecular Bioscience, 2013
- Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dual responseJournal of Materials Chemistry B, 2012
- High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterizationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosisJournal of Experimental & Clinical Cancer Research, 2010
- Enhancement of cisplatin sensitivity in lewis lung carcinoma by liposome-mediated delivery of a survivin mutantJournal of Experimental & Clinical Cancer Research, 2010
- Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancerCancer Immunology, Immunotherapy, 2005
- Interaction of polynucleotides with cultured mammalian cells: II. Cell surface charge density and RNA uptakeExperimental Cell Research, 1973